Skip to main content

Month: June 2022

ICG Enterprise Trust Plc: Results of 2022 Annual General Meeting

ICG Enterprise Trust plc (the “Company”) 28 June 2022 Results of 2022 Annual General Meeting The Company announces that at its Annual General Meeting (“AGM”) held this afternoon, all resolutions proposed were duly passed by the requisite majority the details of which are set out in the table below:RESOLUTION VOTES FOR % FOR VOTES AGAINST % AGAINST VOTES TOTAL % OF ISC VOTED VOTES WITHHELD1. To receive and adopt the reports of the directors and auditors and the Company’s financial statements. 22,069,842 97.73 512,610 2.27 22,582,452 32.96% 47,7722. To declare a final dividend. 22,571,096 99.97 6,312 0.03 22,577,408 32.95% 52,8163. To re-elect J. Tufnell as a director. 20,675,427 91.69 1,874,064 8.31 22,549,491 32.91% 80,7334. To re-elect A. Bruce as a director. 22,282,669 98.85 259,957 1.15 22,542,626 32.90% 87,5985. To...

Continue reading

Adial Pharmaceuticals Provides Letter to Shareholders From CEO William Stilley

CHARLOTTESVILLE, Va., June 28, 2022 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), today issued the following letter to its shareholders from the Company’s CEO, William Stilley. Dear Shareholders, It continues to be my great honor to serve you as CEO of Adial Pharmaceuticals, especially at this momentous time when you and I, anxiously yet optimistically, await top-line results from the ONWARD™ Phase 3 clinical trial. Yesterday, we announced database lock for ONWARD, and today, I want to take this opportunity to personally write to you. Great care was taken to verify and validate the integrity of all data collected during ONWARD, all of which remained blinded throughout. Now that database lock is complete, meaning the dataset has been permanently set, the data has been transferred...

Continue reading

Albioma : Presentation of 2022 first-half results

Presentation of 2022 first-half results Frédéric Moyne, Chairman & CEO of Albioma, and Julien Gauthier, Deputy CEO – Finance, are pleased to invite you to attend a conference call organised on 26 July 2022, at 6:00 pm (CET), to present the results of the first half of the 2022 financial year. The presentation will be in French, a simultaneous translation into English will be provided. You are kindly invited to dial in using one of the following numbers. France:                   +33 (0)1 76 77 28 19 United Kingdom:        +44 (0)330 165 4012 Brazil:                     +55 11 3181 5422 Confirmation code:      6337772 To follow the online presentation, join the webcast using this link:https://globalmeet.webcasts.com/starthere.jsp?ei=1557050&tp_key=02bad5e876  AttachmentAlbioma_Invitation_conference_analystes_20220726_ENG ...

Continue reading

Workplace Options acquires Essi Systems’ stress, resiliency and emotional intelligence assessments and behavior change tools to enhance its digital wellbeing solutions offerings

RALEIGH, N.C., June 28, 2022 (GLOBE NEWSWIRE) — Workplace Options, a leading provider of integrated global wellbeing solutions, announced that it acquired Essi Systems’ stress, resiliency and emotional intelligence assessments and behavior change tools. Essi Systems is an international management consulting company that has been delivering scalable human capital solutions to improve employee health and optimize performance to more than 4,000 organizations in thirty countries worldwide for over 35 years. “This acquisition will strengthen Workplace Options’ suite of digital services, adding new tools to our suite of emotional, practical, and physical solutions,” says Alan King, President, and CEO at Workplace Options. “Our clients will benefit from the assessments and behavioral change tools that Essi Systems developed to further...

Continue reading

Tristan Tahmaseb Announced as Recipient of The M&A Advisor’s 13th Annual Emerging Leaders Awards

ST. LOUIS, June 28, 2022 (GLOBE NEWSWIRE) — Saint Louis, MO, June 2022 –The M&A Advisor announced Tristan Tahmaseb, Senior Associate, ButcherJoseph & Co., as one of the recipients of the 13th Annual Emerging Leaders Awards.   The M&A Advisor, renowned globally for its recognition and presentation of leading M&A, financing, and turnaround professionals, created this recognition awards program to promote mentorship and professional development amongst the emerging leaders of corporate finance and dealmaking industries.  Tristan has been chosen from a pool of prominent nominees for his notable accomplishments in business and in service to the community.  Evaluation and selection of the nominees was completed by an independent judging panel.  “The Emerging Leaders Awards were born as the ‘40 Under 40 Awards’...

Continue reading

Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions

The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to patient Yardley, PA, June 28, 2022 (GLOBE NEWSWIRE) — Norstella, an organization that helps life sciences companies navigate the complexities of the drug life cycle, and Citeline (formerly Pharma Intelligence)—a leading provider of specialist intelligence, data and software for clinical trials, drug development and regulatory compliance—have announced an agreement to merge the companies. By uniting Norstella, which is comprised of four prominent pharmaceutical solutions providers—Evaluate, MMIT, Panalgo and The Dedham Group—with Citeline, the combined company will be well positioned to help life sciences companies reach patients faster by providing clients with the intelligence...

Continue reading

BBS-Bioactive Bone Substitutes Plc: Trading on BBS’s warrants begins on First North Growth Market Finland

BBS-Bioactive Bone Substitutes Plc   Company Announcement 28 June 2022 17.00 (CEST) Trading on warrants 1-2022 (TO1) ja 2-2022 (TO2) issued by BBS-Bioactive Bone Substitutes Plc (“BBS” or the “Company”) begins on First North Growth Market Finland approximately on 1 July 2022. Since only 8,084 warrants of series 1-2022 (TO1) and 2-2022 (TO2) each were subscribed in Sweden by a total of 199 subscribers, the warrants will not be subject to trading on First North Growth Market Sweden. BBS will provide the investors who have subscribed for warrants in Sweden and whose warrants have been delivered through the book-entry system maintained by Euroclear Sweden AB instructions on how to convert their warrants into warrants that are in the book-entry system maintained by Euroclear Finland Oy which can be traded on First North Growth Market Finland....

Continue reading

BASF expands capacity for key specialty amines in North America

Focus on polyetheramines and tertiary aminesIncrease of production capacities at Geismar site on-stream in mid-2023BASF aims to reliably support customers in North AmericaFLORHAM PARK, N.J., June 28, 2022 (GLOBE NEWSWIRE) — BASF will increase the production capacity for key specialty amines manufactured at its Geismar, Louisiana site. After the completed production capacity expansion of a flexible world-scale production asset by mid-2023, BASF will be able to produce more of its key polyetheramines and tertiary amines marketed under the Baxxodur® and Lupragen™ brands. These assets in North America will complement a global network of specialty amines production plants including those at Verbund sites in Ludwigshafen, Germany, and in Nanjing, China. “This investment underlines our commitment to continuously support the growth...

Continue reading

Photocat and Alumichem agrees that Photocat should take over Alumichem De-Icer and Dust reduction product known as CMA.

June 28th 2022 Photocat and Alumichem agrees that Photocat should take over Alumichem De-Icer and Dust reduction product known as CMA. Photocat announce today that it has agreed with Danish Alumichem A/S from Birkerød to take over its CMA (Calcium Magnesium Acetate) business. The deal will be effective from second half of the year 2022. CMA is known as sustainable de-icer product which have properties of being highly effective, require fewer applications, be good for pets and wildlife, reduce corrosion and additional benefits. It is a good fit to Photocat and it has been proven to reduce particles in the air with around 30%. Particles is together with NOx the 2 main problems in air quality problem in our modern cities. The market for CMA solutions is expected to increase over the coming 10 years with a double-digit figure in the first...

Continue reading

ICG Enterprise Trust Plc: Q1 Update for the three months ended 30 April 2022

ICG Enterprise Trust plcQ1 Update for the three months ended 30 April 202228 June 2022 NAV per Share Total Return of 4.5% in the first quarter; 27.9% in the last twelve monthsHighlightsNAV per Share of 1,761p (31 January 2022: 1,690p), NAV per Share Total Return of 4.5% during the quarter; 27.9% during the last twelve months Portfolio Return on a Local Currency Basis during the quarter of 2.0% (Sterling return: 5.2%); 30.2% during the last twelve months. Portfolio valued at £1,244m on 30 April 2022 Disciplined transaction activity: new Investments of £59.1m and Realisation Proceeds of £48.8m during the quarter, including 17 Full Exits executed at an average of 23% Uplift to Carrying Value and 2.7x Multiple to Cost First quarter dividend of 7p per share; progressive dividend policy maintained Revolving Credit Facility increased to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.